Literature DB >> 9509416

Immunoblot analyses on the differential distribution of NR2A and NR2B subunits in the adult rat brain.

D H Jin1, Y W Jung, B H Ko, I S Moon.   

Abstract

Quantitative immunoblot analyses were carried out to study the distribution of N-methyl-D-aspartate (NMDA) receptor subunit 2A and 2B (NR2A and NR2B, respectively) at the protein level in the adult rat brain. Highest levels of NR2A were detected in cerebral cortex and hippocampus, followed at more or less similar levels (about 36-72% of cerebral cortex) by striatum, thalamus, olfactory bulb, superior and inferior colliculi, and cerebellum. The lowest levels were detected in midbrain and lower brain stem (30-31% of cerebral cortex). The NR2B was more dramatic in differential distribution than the NR2A. Highest levels of NR2B were found in telencephalic (olfactory bulb, cerebral cortex, hippocampus, and striatum) and thalamic regions, and expression in superior and inferior colliculi, midbrain, lower brain stem, and cerebellum were significantly lower (4-25% of cerebral cortex). Interestingly, NR2B proteins were barely detectable in the cerebellum. When the postsynaptic density (PSD) fractions were compared, the amount of NR2B in the cerebellar PSD fraction was only 1.8% of that present in the cerebral PSD fraction where the subunit is highly enriched. Immunoblot analyses with a phosphotyrosine-specific antibody showed that the molecular sizes of major phosphotyrosine-containing proteins in forebrain and hindbrain are 180 and 45 kDa, respectively. The regional distribution of the 180 kDa major phosphotyrosine protein was very similar to that of NR2B, and the protein could be immunoprecipitated by NR2B antibody. Our data shows that NR2A and NR2B subunits are differentially distributed in the brain in an overlapping manner, and that the major phosphotyrosine-containing protein of 180 kDa in forebrain is the NR2B.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9509416

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  8 in total

1.  Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning.

Authors:  S M Rodrigues; G E Schafe; J E LeDoux
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

Review 2.  Modulation of NMDA receptors in the cerebellum. 1. Properties of the NMDA receptor that modulate its function.

Authors:  Marta Llansola; Ana Sanchez-Perez; Omar Cauli; Vicente Felipo
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

3.  Distribution of NMDA and AMPA receptor subunits at thalamo-amygdaloid dendritic spines.

Authors:  Jason J Radley; Claudia R Farb; Yong He; William G M Janssen; Sarina M Rodrigues; Luke R Johnson; Patrick R Hof; Joseph E LeDoux; John H Morrison
Journal:  Brain Res       Date:  2007-01-17       Impact factor: 3.252

4.  Blockade of NMDA GluN2B receptors selectively impairs behavioral flexibility but not initial discrimination learning.

Authors:  Gemma L Dalton; Liya M Ma; Anthony G Phillips; Stan B Floresco
Journal:  Psychopharmacology (Berl)       Date:  2011-03-08       Impact factor: 4.530

5.  Regulation of NMDA receptors by cyclin-dependent kinase-5.

Authors:  B S Li; M K Sun; L Zhang; S Takahashi; W Ma; L Vinade; A B Kulkarni; R O Brady; H C Pant
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

Review 6.  Glutamate receptors as therapeutic targets for Parkinson's disease.

Authors:  Kari A Johnson; P Jeffrey Conn; Colleen M Niswender
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

Review 7.  Glutamate receptors and Parkinson's disease: opportunities for intervention.

Authors:  Michael J Marino; Ornella Valenti; P Jeffrey Conn
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 8.  Roles of Glutamate Receptors in Parkinson's Disease.

Authors:  Zhu Zhang; Shiqing Zhang; Pengfei Fu; Zhang Zhang; Kaili Lin; Joshua Ka-Shun Ko; Ken Kin-Lam Yung
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.